Latest News
Press Releases
August 31, 2022
IAVI announces first vaccinations at Liberia site in Phase I clinical trial of Lassa fever vaccine candidate
August 29, 2022Japan reiterates commitment to HIV vaccine development with a $10.5 million contribution to IAVI
May 18, 2022IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program
April 7, 2022IAVI and Moderna partner to tackle broad global health priorities using mRNA for vaccines and antibodies
February 2, 2022IAVI appoints three notable global health and business leaders to its board of directors
Features
September 20, 2022
IAVI scientists publish findings that suggest intranasal vaccination can prevent COVID-19 breakthrough infections in small animal models
September 1, 2022IAVI launches toolkit to build vaccine literacy knowledge
August 29, 2022Donor Spotlight: Japanese Government
August 17, 2022IAVI contributes to WHO proposed framework for evaluating the effectiveness of new COVID-19 vaccines
July 27, 2022Read: WHO preferred product characteristics for monoclonal antibodies (mAbs) for HIV prevention
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
